BONTRIL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Bontril, and when can generic versions of Bontril launch?
Bontril is a drug marketed by Valeant and is included in two NDAs.
The generic ingredient in BONTRIL is phendimetrazine tartrate. There are five drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the phendimetrazine tartrate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Bontril
A generic version of BONTRIL was approved as phendimetrazine tartrate by VIRTUS on December 31st, 1969.
Summary for BONTRIL
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 37 |
Clinical Trials: | 2 |
Patent Applications: | 3,765 |
Formulation / Manufacturing: | see details |
DailyMed Link: | BONTRIL at DailyMed |
Recent Clinical Trials for BONTRIL
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
William Stoops | Phase 1 |
University of Kentucky | Phase 1 |
National Institute on Drug Abuse (NIDA) | Phase 1 |
US Patents and Regulatory Information for BONTRIL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Valeant | BONTRIL | phendimetrazine tartrate | CAPSULE, EXTENDED RELEASE;ORAL | 088021-001 | Sep 21, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Valeant | BONTRIL PDM | phendimetrazine tartrate | TABLET;ORAL | 085272-001 | Approved Prior to Jan 1, 1982 | AA | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |